Trying to separate three different claims about GHK-Cu: that it is the right molecule, that it is the right dose, and that it does something useful.
The measured outcome and the hoped-for outcome are rarely the same thing in these threads.
Baseline first. Without a baseline the after picture is decoration.
Injection site reactions are trivial until they are not, and a fresh needling technique removes half of them.
Where does the human data stop and the extrapolation start?
My rule, after years of this: if it cannot survive being written down with the numbers attached, it is marketing.
Three questions kill most of the confidence in a thread like this: sample size, blinding, who paid.
Is a baseline blood test really necessary before starting something like this?
Read methods.